Skip to main content

Advertisement

SpringerLink
Log in

Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hu Y, Li L, Xu Y et al (2011) Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and beta-cell function in subjects with long-term remission. Diabetes Care 34:1848–1853

    Article  PubMed  CAS  Google Scholar 

  2. Peyrot M, Rubin RR, Lauritzen T et al (2005) Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 28:2673–2679

    Article  PubMed  Google Scholar 

  3. Saisho Y, Kou K, Tanaka K et al (2011) Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes. Endocr J 58:315–322

    Article  PubMed  CAS  Google Scholar 

  4. Kim BY, Jung CH, Mok JO, Kang SK, Kim CH (2012) Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients. Acta Diabetol 49:9–15

    Article  PubMed  CAS  Google Scholar 

  5. Meier JJ, Menge BA, Breuer TG et al (2009) Functional assessment of pancreatic beta-cell area in humans. Diabetes 58:1595–1603

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan

    Yoshifumi Saisho, Kinsei Kou, Kumiko Tanaka, Toshihide Kawai & Hiroshi Itoh

  2. Center for Clinical Research, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan

    Takayuki Abe

  3. Department of Internal Medicine, Saiseikai Central Hospital, Shinjuku-ku, Tokyo, Japan

    Akira Shimada

Authors
  1. Yoshifumi Saisho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kinsei Kou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kumiko Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takayuki Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akira Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshihide Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroshi Itoh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshifumi Saisho.

Additional information

Communicated by Renato Lauro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saisho, Y., Kou, K., Tanaka, K. et al. Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes. Acta Diabetol 50, 987–988 (2013). https://doi.org/10.1007/s00592-012-0441-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-012-0441-y

Keywords

Search

Navigation